Journal
PREVENTIVE VETERINARY MEDICINE
Volume 98, Issue 1, Pages 19-28Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.prevetmed.2010.09.022
Keywords
PMWS severity; PCV2 PCR; Morbidity
Categories
Funding
- BBSRC CEDFAS initiative [BB/FO18394/1]
- BPEX Ltd.
- BioBest Laboratories Ltd.
- Pfizer Animal Health Ltd.
- Biotechnology and Biological Sciences Research Council [BB/E018394/1] Funding Source: researchfish
- BBSRC [BB/E018394/1] Funding Source: UKRI
Ask authors/readers for more resources
Post-weaning multi-systemic wasting syndrome (PMWS) causes major economic losses for the English pig industry and severity of clinical signs and economic impact vary considerably between affected farms. We present here a novel approach to quantify severity of PMWS based on morbidity and mortality data and presence of porcine circovirus type 2 (PCV2). In 2008-2009, 147 pig farms across England, non-vaccinating for PCV2, were enrolled in a cross-sectional study. Factor analysis was used to generate variables representing biologically meaningful aspects of variation among qualitative and quantitative morbidity variables. Together with other known variables linked to PMWS, the resulting factors were included in a principal component analysis (PCA) to derive an algorithm for PMWS severity. Factor analysis resulted in two factors: Morbidity Factor 1 (MF1) representing mainly weaner and grower morbidity, and Morbidity Factor 2 (MF2) which mainly reflects variation in finisher morbidity. This indicates that farms either had high morbidity mainly in weaners/growers or mainly in finishers. Subsequent PCA resulted in the extraction of one component representing variation in MF1, post-weaning mortality and percentage of PCV2 PCR positive animals. Component scores were normalised to a value range from 0 to 10 and farms classified into: non or slightly affected farms with a score <4, moderately affected farms with scores 4-6.5 and highly affected farms with a score >6.5. The identified farm level PMWS severities will be used to identify risk factors related to these, to assess the efficacy of PCV2 vaccination and investigating the economic impact of potential control measures. (C) 2010 Elsevier BM. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available